[Changes in cytokine production by pulmonary alveolar macrophages collected from rats that have been treated with erythromycin for an extended period].
Sugiyama
Y
Y
Kitamura
S
S
Yanagisawa
K
K
Tominaga
S
S
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D019743:Chemokines, CXC / Q000096:biosynthesis*; D002630:Chemotactic Factors / Q000096:biosynthesis*; D004917:Erythromycin / Q000494:pharmacology*; D006133:Growth Substances / Q000096:biosynthesis*; D036341:Intercellular Signaling Peptides and Proteins; D016676:Macrophages, Alveolar / Q000276:immunology*; D051381:Rats; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D000900:Anti-Bacterial Agents; D019743:Chemokines, CXC; D002630:Chemotactic Factors; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D014409:Tumor Necrosis Factor-alpha; D004917:Erythromycin